Skip to main content
Thoracic Cancer logoLink to Thoracic Cancer
. 2021 Mar 11;12(9):1312–1319. doi: 10.1111/1759-7714.13873

Identification of differentially expressed circular RNAs associated with thymoma

Qingjun Wu 1, Xuanmei Luo 2, Hexin Li 3, Lili Zhang 3, Fei Su 3, Shifang hou 4, Jian Yin 4, Wei Zhang 5,, Lihui Zou 2,
PMCID: PMC8088952  PMID: 33704915

Abstract

Background

Thymomas and thymic carcinomas are the most common tumor types among anterior mediastinal lesions. However, the relationship between molecular aberrations and thymoma patients are poorly understood, especially abnormal changes in the expression profiles of circRNAs. The purpose of the present study was to investigate the expression profiles of circRNAs in thymoma patients and their possible roles in the pathogenesis of thymoma.

Methods

Diseased tissues and surrounding normal thymic tissues in two thymoma patients were collected for circRNA sequencing. The top four upregulated circRNAs were selected as candidates and further validated with RT‐PCR in 20 thymoma patients. Gene ontology and signal transduction network analyses of circRNA‐related mRNAs were performed to analyze the functional properties. Survival analysis of their parental genes were also carried out to evaluate the clinical value of differentially expressed circRNA.

Results

A total of 73 circRNAs were differentially expressed in thymoma tissues using high‐throughput sequencing. Among these circRNAs, hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 were significantly upregulated in thymoma tissues compared with normal thymic tissues. We identified that these four circRNA‐related mRNAs were involved in cell–cell adhesion, MAPK pathways, and TNF pathway, which may contribute to the pathological immune disorder in thymoma. Finally, we also found that SCAP (hsa_circ_0007291 parental gene) and AFF2 (hsa_circ_0001947 parental gene) were all significantly related with progression‐free survival (PFS) of thymoma patients in a Kaplan‐Meier plot (p‐value <0.05).

Conclusions

The expression levels of hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 were significantly upregulated and positively correlated with immune imbalance in thymoma patients.

Keywords: circRNAs, immune imbalance, thymoma


The expression levels of hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 were significantly upregulated and positively correlated with immune imbalance in thymoma patients. The discovery of new differentially expressed circRNAs can be used not only as a biomarker for diagnosis, but also as a potential target for the treatment of thymoma.

graphic file with name TCA-12-1312-g003.jpg

INTRODUCTION

Thymoma is a neoplasm with complex histological and biological behaviors that often occurs in the anterior mediastinum. 1 Patients with thymomas are often asymptomatic at the initial stage, and they are often unintentionally found during physical examination. Chest imaging examination usually shows a round or lobulated tumor in the anterior mediastinum. 2 There are no effective preventive measures for thymoma, but early diagnosis and early treatment are keys to disease control. Thymomas should be surgically removed as soon as possible, and pathological biopsies used to guide postoperative treatment. 3

The etiology of thymoma remains to be fully elucidated, but may be related to genetic inheritance. In addition, the thymus is the main place for T lymphocytes to mature and has an indispensable effect on cellular immunity. Therefore, the global gene expression profile of thymic tissue in thymoma patients, especially the immune‐related expression profile, needs to be further studied.

CircRNAs (circular RNA molecules) are a kind of non‐coding RNA molecule that do not have a 5′‐ terminal hat and a 3′‐ terminal poly (A) tail and form a ring structure with covalent bonds. Most circRNA are derived from exons and a few are formed by direct cyclization of introns. 4 Recent studies have shown that circRNA molecules are rich in miRNA response elements (MRE) ,and act as an miRNA sponge to indirectly regulates the expression of target genes downstream of miRNA, which is called the competitive endogenous RNA (ceRNA) mechanism. 5 Due to the spatiotemporal specificity and disease specificity of expression, circRNAs are expected to have importance in normal development of tissues but also in disease pathogenesis. A number of investigations have demonstrated that circRNAs are associated with several types of cancer, such as gastric cancer, papillary thyroid cancer, hepatocellular carcinoma, and malignant melanoma. 6 , 7 , 8 , 9

In the present study, RNA sequencing (RNAseq) was performed to detect the expression of circRNAs, and their expressions were further validated in thymoma patients. The functional analysis of circRNAs‐related miRNAs and their regulated target genes revealed the immunomodulatory role of circRNAs in the pathogenesis of thymoma.

METHODS

Thymoma patients and thymus tissue samples

Clinical specimens were collected from 22 patients who underwent thymoma resection in Beijing Hospital from January 2018 to December 2019. All samples were diagnosed as type B2 thymoma according to the World Health Organization criteria. The non‐neoplastic thymic tissue adjacent to the tumor tissue served as the normal control. None of the patients received radiotherapy, chemotherapy or other treatment before the operation. The study was approved by the ethics committee of Beijing Hospital (2020BJYYEC‐007‐02), and all the subjects signed informed consent forms.

RNA extraction and RNA‐seq

Total RNA was extracted from liquid nitrogen frozen thymoma tissue and adjacent normal tissue by the Trizol method (Invitrogen, Thermo Fisher Scientific). The quality of RNA was detected by Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific), and the integrity of RNA was verified by gel electrophoresis. After removing rRNA and linear RNA, random primers were amplified and reverse transcribed into fluorescence‐labeled cDNA to complete the preparation of the whole library. The constructed library was sequenced with Illumina HiSeq cDNA 2000. The read quality was filtered through a 4‐base sliding window with an average quality threshold of 15, while reads with a length of less than 28 were discarded. The filtered reads were mapped to the human hg38 genome by aligner software STAR. 10 This part of the work was entrusted to Annoroad Gene Institute (Beijing, China).

Quantitative real‐time PCR

A total of 5 μg total RNA was digested with Rnase R at 37°C for 1 h, and then the first strand of cDNA was synthesized by routine SuperScript First‐Strand Synthesis System (Takara Biotechnology) for RT‐PCR Kit for circRNA amplification. The real‐time quantitative PCR was performed with SYBR‐Green Premix Ex Taq (Takara Biotechnology Co., Ltd) and the iQ5 Multicolor Real‐Time PCR Detection System (Bio‐Rad Laboratories) according to the manufacturer's protocol. The PCR primers for hsa_circ_0001173 were AGAGGCTACGGGAGGAGAAC (forward) and TCTGCTGGCAATTCAAACAC (reverse). The primers for hsa_circ_0007291 were TCATGTCTGTGGGACTCTGC (forward) and CCAGGGAAACACTGAGGACT (reverse). The primers for hsa_circ_0003550 were ACGGGAAGCGATGATAACTG (forward) and TGGTATCCCAGATCCTCAGC (reverse). The primers for hsa_circ_0001947 were CAGTGCAGCCAGTTCAAAGA (forward) and AGTTTCCAAGCGTGTTCTGG (reverse). The primers for the ß‐actin gene were GGCGGCACCACCATGTACCCT (forward) and AGGGGCCGGACTCGTCATACT (reverse). The PCR reaction required 10 μl 2 × SYBR‐Green Premix EX Taq reagent, 50 ng DNA, 1 μl of gene primer in a total volume of 20 μl. The reaction conditions included initial denaturation at 95°C for 30 s, 40 cycles of denaturation at 95°C for 5 s, annealing at 60°C for 30 s, followed by 81 cycles of dissociation at 55°C for 30 s. The specificity of amplification was determined by analyzing the dissolution curve of the product. The relative expression of circRNA was calculated by CT value method, and each experiment was repeated at least three times.

Target prediction of circRNAs

The circRNA–miRNA–mRNA network was developed based on the same expression trend between circRNA and its corresponding mRNA. The circRNAs interacted miRNAs were predicted using cytoscape. 11 The regulatory network between miRNA and its downstream genes was predicted by mirdb software. 12 Meanwhile, interactive scores were provided to evaluate accuracy, and only differential expression genes (DEGs) with scores greater than 90 were selected for further analysis.

Functional enrichment analysis and survival analysis

Based on the DEGs in the preliminary circRNA–miRNA–mRNA regulatory network, a further analysis of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway was performed using ggplot2 software. 13 In addition, to evaluate the prognostic value of the circRNAs, the influence of circRNAs parental genes on survival of thymoma patients was also analyzed. The TCGA thymoma (PRAD) data was selected in UCSC Xena 14 to obtain the Kaplan–Meier plot of the circRNA parental gene.

Statistical analysis

All the data were analyzed using the Statistical Product and Service Solutions (SPSS) 20.0 software package (IBM SPSS) and GraphPad Prism 6.0 (GraphPad Software, Inc.). All data were expressed as the mean ± SD. A Student's t‐test was used to compare the measurement data between the two groups. The threshold of significance was defined as a p‐value <0.05.

RESULTS

Differential expression profile of circRNA in thymus tissue of patients with thymoma

In total, 73 circRNAs were differentially expressed in both thymoma patients, of which 35 were upregulated and 38 were downregulated (Figure 1(a)). Since the upregulated circRNAs are more suitable as biomarkers than the downregulated circRNAs, the top four circRNAs from upregulated circRNAs were selected for further analysis (Table 1). Figure 1(b) demonstrated that the expression levels of four selected circRNAs were significantly upregulated in thymoma tissue, but there was no significant difference in the corresponding parental genes. Next, we investigated the exon composition of these four circRNAs. Most circular RNAs contained multiple exons, only hsa_circ_0001947 contained one annotated exon (Figure 1(c)). Similarly, the heat map results showed the expression levels of selected four circRNAs in thymoma tissue were higher than that in normal tissues in both thymoma patients (Figure 1(d)).

FIGURE 1.

FIGURE 1

Upregulated circRNAs in thymoma tissues and adjacent normal tissues. (a) The volcano plots of upregulated circRNAs in thymoma tissues and normal tissues. The red points represent upregulated circRNAs in thymoma tissue with p < 0.05. (b) The expression levels of circRNAs and their parental mRNAs in thymoma tissues and adjacent normal tissues. (c) Schematic diagram of exon composition of hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947. (d) The heatmap of four selected circRNAs in thymoma patients

TABLE 1.

Detailed information of the four selected circRNAs

circRNA ID Chrom Start End Strand Cognate mRNA Parental gene
hsa_circ_0001173 chr20 58 438 944 58 441 083 + ENST00000475243.5 VAPB
hsa_circ_0007291 chr3 47 425 484 47 428 670 ENST00000265565.10 SCAP
hsa_circ_0003550 chr4 10 097 710 10 103 986 ENST00000499869.7 WDR1
hsa_circ_0001947 chrX 148 661 907 148 662 768 + ENST00000370460.7 AFF2

Validation of the differentially expressed circRNAs

The potential candidate circRNAs from high‐throughput sequencing were validated using specific divergent primers spanning the back‐splice junction site. 15 , 16 As shown in Figure 2, the expression levels of hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 were significantly upregulated in thymoma tissue compared with control tissues (p‐values were all less than 0.01).

FIGURE 2.

FIGURE 2

The validation of the expression levels of hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 in 20 thymoma tissues and corresponding adjacent normal tissues using quantitative real‐time polymerase chain reaction

Prediction of the circRNA‐miRNA‐mRNA interaction

CircRNA can bind to the corresponding microRNA like a sponge and participates in the regulation of target gene expression, which is called the competitive endogenous RNA (ceRNA) mechanism. To further investigate the functions of selected circRNAs, the present study investigated the potential miRNAs binding with the circRNA based on the miRNA response element. As shown in Figure 3, a total of four circRNAs and 214 miRNAs were involved in the network, of which most of the miRNAs were regulated by hsa_circ_0007291 and hsa_circ_0001947 according to the p‐value. At the same time, computational miRNA target mRNA analysis was performed by combining mRNA and circRNA expression profiling. In total we obtained 3456 possible miRNA‐mRNA target pairs with the mirdb software (mRNAs are not shown in the figure due to the large number). Some mRNAs were associated with more than one miRNA, such as NM_001455 was targeted by hsa‐miR‐1‐5p, hsa‐miR‐182‐5p, hsa‐miR‐21‐3p and hsa‐miR‐5006‐5p.

FIGURE 3.

FIGURE 3

The network between hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 and their predicted miRNAs

Pathway analysis of differentially expressed genes

In order to further explore the potential pathogenesis of thymoma, we analyzed the biological function of 1792 DEGs in the regulatory network through KEGG pathway analysis. KEGG analysis demonstrated that there were 475 enrichment items from all four circRNAs that were statistically significant (p < 0.05), including the apoptotic process, pathway in cancer, PI3K‐AKT signal pathway, and so on (Figure 4(a)). Meanwhile, a total of 172, 264, 79, and 280 enrichment items were involved in the downstream pathway of hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947, respectively. The top KEGG pathway items that were the most meaningful are shown in Figure 4(b)–(e). Among them, cell–cell adhesion, MAPK pathway, TNF pathway etc. attracted our attention because of their participation in immune response.

FIGURE 4.

FIGURE 4

Prediction of circRNAs/miRNAs‐mediated pathways. (a) The related pathways of all four circRNAs. Only differentially expressed mRNAs with a prediction score greater than 90 were considered. (b) The statistically significant downstream pathway of hsa_circ_0001173, (c) hsa_circ_0007291, (d) hsa_circ_0003550, and (e) hsa_circ_0001947

Survival analysis of parental genes of circRNAs

To further explore the function of circRNA, we examined the survival rates of VAPB, SCAP, WDR1, and AFF2, the parental genes of hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947. As shown in Figure 5, SCAP and AFF2 were significantly associated with overall survival using the Kaplan–Meier survival analysis. Patients with high expression of SCAP and AFF2 showed better overall survival. The results indicated that circRNA might be involved in the pathogenesis of thymoma by transcriptionally regulating the expression of parental genes or some other way. However, this hypothesis needs to be confirmed by further studies.

FIGURE 5.

FIGURE 5

Survival analysis of parental genes of hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 in thymoma. The red lines and blue lines represent the high expression and low expression of the corresponding parent genes, respectively

DISCUSSION

The present study demonstrated that hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 were expressed at high levels and associated with important pathological pathways in thymoma patients. Furthermore, the expression of the parental gene of hsa_circ_0007291 and hsa_circ_0001947 was associated with survival rate of thymoma patients. Hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 may not only be a potential biomarker, but also may be involved in the pathogenesis.

The thymus is where T cells differentiate, develop and mature, and it also secretes thymic hormones with immunomodulatory function, thus it is closely related to immunity. In the pathway analysis of circRNA regulatory genes, we focused on immune‐related signaling pathways. Among them, cell–cell adhesion, MAPK pathway and tumor necrosis factor (TNF) pathway were of great interest because of their participation in immune response. Cell adhesion is a critical step in many immunological processes, including the binding of leukocytes to endothelial cells, infiltration of cells into inflammatory tissues and cytotoxicity to target cells. 17 MAPK activation induces the expression of multiple genes that together regulate the inflammatory response. 18 TNF plays an important role in the typical immune response by regulating the immediate inflammatory response involved in a series of significant innate immunity, as well as the subsequent activation of proliferation and programmed cell death or necrosis. 19 Therefore, it is very likely that hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 participate in the abnormal immune regulation of thymus through these signal pathways.

Previous studies have revealed that circRNA performs its biological function mainly through the following three aspects. First, circRNA cis‐regulates the expression of its parental gene20, 21 second, circRNA adsorbs miRNA through the mechanism of ceRNA22, 23 and third, CircRNA can also regulate gene transcription by binding to RNA binding proteins. 24 , 25 Although the differential expressions of circRNAs were obvious in thymoma tissues and normal tissues, the mRNA expression levels of their parental genes were not obvious (Figure 1(b)), indicating that the cis‐regulation of these four circRNAs on their parent genes was not strong. Therefore, we speculated that these four circRNA function mainly through their downstream miRNAs‐mRNA pathway.

At the same time, we found that SCAP (hsa_circ_0007291 parental gene) and AFF2 (hsa_circ_0001947 parental gene) were all significantly related with progression‐free survival (PFS) of thymoma patients in the Kaplan‐Meier plot. SCAP has been shown to specifically regulate the innate immune signal pathway induced by cytosolic cicrobial DNAs stimulation 26 , 27 and protect mice from systemic inflammation. 28 The DEKAFF2 fusion was the likely driver event in the squamous cell carcinoma of head and neck 29 and stimulated T cell activation by interferon‐γ (IFN‐γ) secretion. 30 Therefore, hsa_circ_0007291 and hsa_circ_0001947 may also participate in immune disorders by affecting the instability of the parental gene SCAP and AFF2.

In the preliminary exploration of this study, hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 in thymoma tissues showed some potential as biomarkers of disease, such as high specific expression, sensitive detection, and correlated with patient survival rates. However, the number of samples used in this study was small, which will affect the accuracy of the analysis results. The present study results need to be further verified in larger cohorts. Moreover, in addition to the prediction of bioinformatics software, further experiments are needed to confirm the relationship between CircRNAs and miRNAs. Whether hsa_circ_0001173, hsa_circ_0007291, hsa_circ_0003550, and hsa_circ_0001947 can be used as biomarkers of thymoma patients in clinical diagnosis and treatment remains to be further studied.

In summary, elucidating the specific molecular mechanism of immune response from the perspective of circRNA can provide a more effective diagnosis, prevention and treatment for thymoma, and it is also of great value to the research and development of drugs to improve thymoma therapy.

CONFLICT OF INTEREST

The authors had no conflicts of interest and no disclosures to declare.

ACKNOWLEDGMENTS

This work was supported in part by grants BJ‐2018‐137 and BJ‐2019‐149 from the Beijing Hospital Nova Project, grant 2019WJGW‐10‐01 from the Beijing Dongcheng District Outstanding Talent Funding Project, grants 81871107 and 81870048 from the National Natural Science Foundation of China, and grant 2017ZX09304026 from the National Science and Technology Major Project for Significant New Drugs Creation, grant 2018‐I2M‐1‐002 from the CAMS Innovation Fund for Medical Sciences.

Wu Q, Luo X, Li H, et al. Identification of differentially expressed circular RNAs associated with thymoma. Thorac Cancer. 2021;12:1312–1319. 10.1111/1759-7714.13873

Qingjun Wu and Xuanmei Luo contributed equally to this work.

Funding information Beijing Dongcheng District Outstanding Talent Funding, Grant/Award Number: 2019WJGW‐10‐01; Beijing Hospital Nova Project, Grant/Award Numbers: BJ‐2018‐137, BJ‐2019‐149; CAMS Innovation Fund for Medical Sciences, Grant/Award Number: 2018‐I2M‐1‐002; National Natural Science Foundation of China, Grant/Award Numbers: 81870048, 81871107; National Science and Technology Major Project for Significant New Drugs Creation, Grant/Award Number: 2017ZX09304026

Contributor Information

Wei Zhang, Email: zhangwei3392@bjhmoh.cn.

Lihui Zou, Email: zoulihui4371@bjhmoh.cn.

REFERENCES

  • 1. Scorsetti M, Leo F, Trama A, D'Angelillo R, Serpico D, Macerelli M, et al. Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016;99:332–50. [DOI] [PubMed] [Google Scholar]
  • 2. Morgenthaler TI, Brown LR, Colby TV, Harper CM Jr, Coles DT. Thymoma. Mayo Clin Proc. 1993;68(11):1110–23. [DOI] [PubMed] [Google Scholar]
  • 3. Weissferdt A, Kalhor N, Bishop JA, Jang SJ, Ro J, Petersson F, et al. Thymoma: a clinicopathological correlation of 1470 cases. Hum Pathol. 2018;73:7–15. [DOI] [PubMed] [Google Scholar]
  • 4. Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA (New York, NY). 2013;19(2):141–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Wang PL, Bao Y, Yee MC, Barrett SP, Hogan GJ, Olsen MN, et al. Circular RNA is expressed across the eukaryotic tree of life. PloS One. 2014;9(6):e90859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Tang W, Fu K, Sun H, Rong D, Wang H, Cao H. CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer. Mol Cancer. 2018;17(1):137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Bi W, Huang J, Nie C, Liu B, He G, Han J, et al. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1‐dependent activation of β‐catenin pathway. J Exp Clin Cancer Res. 2018;37(1):275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Liu Z, Yu Y, Huang Z, Kong Y, Hu X, Xiao W, et al. CircRNA‐5692 inhibits the progression of hepatocellular carcinoma by sponging miR‐328‐5p to enhance DAB2IP expression. Cell Death Dis. 2019;10(12):900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Luan W, Shi Y, Zhou Z, Xia Y, Wang J. circRNA_0084043 promote malignant melanoma progression via miR‐153‐3p/Snail axis. Biochem Biophys Res Commun. 2018;502(1):22–9. [DOI] [PubMed] [Google Scholar]
  • 10. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA‐seq aligner. Bioinformatics (Oxford, England). 2013;29(1):15–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020; 48(D1): D127–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Liu S, Xie X, Lei H, Zou B, Xie L. Identification of key circRNAs/lncRNAs/miRNAs/mRNAs and pathways in preeclampsia using bioinformatics analysis. Med Sci Monit. 2019;25:1679–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Goldman MJ, Craft B, Hastie M, Repečka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Li XN, Wang ZJ, Ye CX, Zhao BC, Li ZL. Yang Y. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer. J Exp Clin Cancer Res. 2018;37(1):325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Fang Y, Wang X, Li W, Han J, Jin J, Su F, et al. Screening of circular RNAs and validation of circANKRD36 associated with inflammation in patients with type 2 diabetes mellitus. Int J Mol Med. 2018;42(4):1865–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Läubli H, Borsig L. Altered cell adhesion and glycosylation promote cancer immune suppression and metastasis. Front Immunol. 2019;10:2120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Arthur JS, Ley SC. Mitogen‐activated protein kinases in innate immunity. Nat Rev Immunol. 2013;13(9):679–92. [DOI] [PubMed] [Google Scholar]
  • 19. Holbrook J, Lara‐Reyna S, Jarosz‐Griffiths H, McDermott M. Tumour necrosis factor signalling in health and disease. F1000Res. 2019;8: F1000 Faculty Rev–111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, et al. Exon‐intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256–64. [DOI] [PubMed] [Google Scholar]
  • 21. Li F, Zhang L, Li W, Deng J, Zheng J, An M, et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β‐catenin pathway. Oncotarget. 2015;6(8):6001–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Shi X, Sun M, Liu H, Yao Y, Song Y. Long non‐coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339(2):159–66. [DOI] [PubMed] [Google Scholar]
  • 23. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–8. [DOI] [PubMed] [Google Scholar]
  • 24. Pan X, Xiong K. PredcircRNA: computational classification of circular RNA from other long non‐coding RNA using hybrid features. Mol Biosyst. 2015;11(8):2219–26. [DOI] [PubMed] [Google Scholar]
  • 25. Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Goldstein JL, DeBose‐Boyd RA, Brown MS. Protein sensors for membrane sterols. Cell. 2006;124(1):35–46. [DOI] [PubMed] [Google Scholar]
  • 27. Chen W, Li S, Yu H, Liu X, Huang L, Wang Q, et al. ER adaptor SCAP translocates and recruits IRF3 to perinuclear microsome induced by cytosolic microbial DNAs. PLoS Pathog. 2016;12(2):e1005462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Guo C, Chi Z, Jiang D, Xu T, Yu W, Wang Z, et al. Cholesterol homeostatic regulator SCAP‐SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages. Immunity. 2018;49(5):842–56.e7. [DOI] [PubMed] [Google Scholar]
  • 29. Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, et al. COSMIC: somatic cancer genetics at high‐resolution. Nucleic Acids Res. 2017;45(D1):D777–d83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Yang W, Lee KW, Srivastava RM, Kuo F, Krishna C, Chowell D, et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat Med. 2019;25(5):767–75. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thoracic Cancer are provided here courtesy of Wiley

RESOURCES